Abstract
Aim
(1) To describe the prevalence of benzodiazepine use in Belgian nursing homes, with specific attention to indications and dosages. (2) To compare actual and recommended dosages of benzodiazepines for anxiety and insomnia. (3) To explore the risk profile for chronic benzodiazepine use in institutionalised older adults.
Methods
Medication charts of 1,730 residents from 76 nursing homes in Belgium were collected and analysed, using the ATC classification. Drug name, indication and daily dosage were recorded. From authoritative international sources, we extracted for each drug and each indication a daily dosage recommended not to be exceeded in older adults for comparison with observed actual dosages.
Results
Among the chronic benzodiazepine or z-drug (BZD/Z) users (50% of the residents), the leading indication was ‘insomnia’ (59% of the users) followed by ‘anxiety’ (17%) and ‘unrest’ (10%). In the chronic prescriptions of BZD/Zs indicated for insomnia, the actual daily dose exceeded the geriatric upper limit in 95% of lormetazepam prescriptions, 82% of zolpidem, 78% of zopiclone and 35% of lorazepam prescriptions. For anxiety, daily doses also exceeded the limit but not to the same extent. Multivariate analysis showed BZD/Z use was positively associated with pain (OR 1.58, 95% CI 1.27–1.97), constipation (OR 1.43, 95% CI 1.16–1.76) and depression (OR 1.68, 95% CI 1.35–2.08). Residents with dementia were less likely to receive a BZD/Z (OR 0.60, 95% CI 0.48–0.74).
Conclusion
Efforts to reduce the use of BZD/Zs in nursing homes should concentrate on insomnia, with interventions aimed at reducing too high prevalence of chronic use and too high daily dosages in this indication.
Similar content being viewed by others
References
Azermai M, Elseviers M, Petrovic M, Van Bortel L, Stichele RV (2011) Geriatric drug utilisation of psychotropics in Belgian nursing homes. Hum Psychopharmacol. doi:10.1002/hup.1160
Gobert M, D'Hoore W (2005) Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland. Int J Geriatr Psychiatr 20(8):712–721. doi:10.1002/gps.1349
Hosia-Randell H, Pitkala K (2005) Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging 22(9):793–800
Petek Ster M, Cedilnik Gorup E (2011) Psychotropic medication use among elderly nursing home residents in Slovenia: cross-sectional study. Croat Med J 52(1):16–24
Ashton H (1994) Guidelines for the rational use of benzodiazepines—when and what to use. Drugs 48(1):25–40
Neutel CI (2005) The epidemiology of long-term benzodiazepine use. Int Rev Psychiatry 17(3):189–197. doi:10.1080/09540260500071863
Canadian Agency for Drugs and Technologies in Health (CADTH) (2010) Benzodiazepines in older adults: a review of clinical effectiveness, cost-effectiveness, and guidelines. http://www.cadth.ca/media/pdf:M0022_Benzodiazepines_Elderly.pdf. Accessed 10 Aug 2011
National Institute for Health an Clinical Excellence (NICE) (2011) Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults. http//www.nice.org.uk/nicemedia/live/13314/52599/52599.pdf. Accessed 10 Aug 2011
Martin JL, Sainz-Pardo M, Furukawa TA, Martin-Sanchez E, Seoane T, Galan C (2007) Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J Psychopharmacol 21(7):774–782. doi:10.1177/0269881107077355
Beland SG, Preville M, Dubois MF, Lorrain D, Voyer P, Bosse C, Grenier S, Moride Y (2011) The association between length of benzodiazepine use and sleep quality in older population. Int J Geriatr Psychiatr 26(9):908–915. doi:10.1002/gps.2623
Lader M, Tylee A, Donoghue J (2009) Withdrawing benzodiazepines in primary care. CNS Drugs 23(1):19–34. doi:10.2165/0023210-200923010-00002
Voyer P, Preville M, Cohen D, Berbiche D, Beland SG (2010) The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Can J Aging 29(2):205–213. doi:10.1017/S0714980810000115
Verdoux H, Lagnaoui R, Begaud B (2005) Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol Med 35(3):307–315. doi:10.1017/s0033291704003897
Wu CS, Wang SC, Chang IS, Lin KM (2009) The association between dementia and long-term use of benzodiazepine in the elderly: nested case–control study using claims data. Am J Geriatr Psychiatry 17(7):614–620
Barker MJ, Greenwood KM, Jackson M, Crowe SF (2004) Cognitive effects of long-term benzodiazepine use—a meta-analysis. Cns Drugs 18(1):37–48
Klotz U (1998) Effect of age on pharmacokinetics and pharmacodynamics in man. Int J Clin Pharmacol Therapeut 36(11):581–585
Petrovic M, Mariman A, Warie H, Afschrift M, Pevernagie D (2003) Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature. Acta Clin Belg 58(1):27–36
Madhusoodanan SBOJ (2004) Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf 3(5):485–493
Cook PJ, Huggett A, Graham-Pole R, Savage IT, James IM (1983) Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepam. Br Med J (Clin Res Ed) 286(6359):100–102
Mustard CA, Mayer T (1997) Case-control study of exposure to medication and the risk of injurious falls requiring hospitalization among nursing home residents. Am J Epidemiol 145(8):738–745
The British National Formularium (BNF). British Medical Association and the Royal Pharmaceutical Society. http://bnf.org:bnf:index.htm. Accessed 10 Aug 2011
KNMP (Royal Dutch Society of Pharmacy) (2009) Informatorium Medicametorum. Koninklijke Nederlandse Maatschappij ter bevordering van de Farmacie. www.knmp.nl. Accessed 8 June 2011
Sweetman SC (ed) Martindale: the complete drug reference, 36th ed. Pharmaceutical Press, London
Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163(22):2716–2724. doi:10.1001/archinte.163.22.2716163/22/2716
Rancourt CMJ, Baillargeon L, Verreault R, Laurin D, Grégoire JP (2004) Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr 4:9
Laroche ML, Charmes JP, Merle L (2007) Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 63(8):725–731. doi:10.1007/s00228-007-0324-2
Stevenson DG, Decker SL, Dwyer LL, Huskamp HA, Grabowski DC, Metzger ED, Mitchell SL (2010) Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry 18(12):1078–1092. doi:10.1097/JGP.0b013e3181d6c0c6
Holmquist IB, Svensson B, Hoglund P (2003) Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol 59(8–9):669–676. doi:10.1007/s00228-003-0679-y
Elseviers MVSR, Soenen K, Gobert M, Van Bortel L, Van De Voorde C (2010) Drug utilisation in Belgian nursing homes: impact of residents' and institutional characteristics. Pharmacoepidemiol Drug Safety 19:1041–1048
Katz S, Akpom CA (1976) 12. Index of ADL. Med Care 14(5 Suppl):116–118
WHO Collaborating Centre for Drug Statistics Methodology (2009) ATC/DDD system. http://www.whocc.no. Accessed 20 June 2011
Westbury J, Jackson S, Gee P, Peterson G (2010) An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUse project. Int Psychogeriatr 22(1):26–36. doi:10.1017/s1041610209991128
Bartlett G, Abrahamowicz M, Tamblyn R, Grad R, Capek R, du Berger R (2004) Longitudinal patterns of new benzodiazepine use in the elderly. Pharmacoepidemiol Drug Saf 13(10):669–682. doi:10.1002/pds.908
Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D (2008) STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Therapeut 46(2):72–83
BCFI (Belgian Centre for Pharmacotherapeutic Information) (2010) Home page. http://www.bcfi.be/. Accessed 8 June 2011
B Terluin FBVH, K Van der Meer, GJH Neomagus, J Hekman, L P J Aulbers, J S Starreveld and M H Grol (2009) NHG-Standaarden Angststoornissen In: NHG-Standaarden voor huisartsened. Nederlandse huisartsen genootschap
Morin AK (2006) Strategies for treating chronic insomnia. Am J Manag Care 12(8 Suppl):S230–S245
van Vliet P, van der Mast RC, van den Brock M, Westendorp RGJ, de Craen AJM (2009) Use of benzodiazepines, depressive symptoms and cognitive function in old age. Int J Geriatr Psychiatr 24(5):500–508. doi:10.1002/gps.2143
Kripke DF (2007) Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry 7:42. doi:10.1186/1471-244X-7-42
Bliwise DL (2004) Sleep disorders in Alzheimer's disease and other dementias. Clin Cornerstone 6(Suppl 1A):S16–S28
Cook JM, Marshall R, Masci C, Coyne JC (2007) Physicians' perspectives on prescribing benzodiazepines for older adults: a qualitative study. J Gen Intern Med 22(3):303–307. doi:10.1007/s11606-006-0021-3
Manji HK, Drevets WC, Charney DS (2001) The cellular neurobiology of depression. Nat Med 7(5):541–547. doi:10.1038/8786587865
Cloos JM, Ferreira V (2009) Current use of benzodiazepines in anxiety disorders. Curr Opin Psychiatry 22(1):90–95. doi:10.1097/YCO.0b013e32831a473d
Ruths S, Straand J, Nygaard HA (2003) Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care 12(3):176–180
Berdot S, Bertrand M, Dartigues JF, Fourrier A, Tavernier B, Ritchie K, Alperovitch A (2009) Inappropriate medication use and risk of falls—a prospective study in a large community-dwelling elderly cohort. BMC Geriatr 9:30. doi:10.1186/1471-2318-9-30
Ensrud KE, Blackwell TL, Mangione CM, Bowman PJ, Whooley MA, Bauer DC, Schwartz AV, Hanlon JT, Nevitt MC (2002) Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 50(10):1629–1637
Boyle N, Naganathan V, Cumming RG (2010) Medication and falls: risk and optimization. Clin Geriatr Med 26(4):583–605. doi:10.1016/j.cger.2010.06.007
Svarstad BL, Mount JK (2001) Chronic benzodiazepine use in nursing homes: effects of federal guidelines, resident mix, and nurse staffing. J Am Geriatr Soc 49(12):1673–1678
Anthierens S, Pasteels I, Habraken H, Steinberg P, Declercq T, Christiaens T (2010) Barriers to nonpharmacologic treatments for stress, anxiety, and insomnia. Family physicians' attitudes toward benzodiazepine prescribing. Can Fam Phys 56(11):E398–E406
Iliffe S, Curran HV, Collins R, Kee SCY, Fletcher S, Woods B (2004) Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers. Aging Mental Health 8(3):242–248. doi:10.1080/13607860410001669778
Cormack MA, Owens RG, Dewey ME (1989) The effect of minimal interventions by general practitioners on long-term benzodiazepine use. J R Coll Gen Pract 39(327):408–411
Gorgels WJ, Oude Voshaar RC, Mol AJ, van de Lisdonk EH, van Balkom AJ, van den Hoogen HJ, Mulder J, Breteler MH, Zitman FG (2005) Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study. Drug and Alcohol Depend 78(1):49–56. doi:10.1016/j.drugalcdep.2004.09.001
Denis C, Fatseas M, Lavie E, Auriacombe M (2006) Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. Cochrane Database Syst Rev 3: CD005194 doi:10.1002/14651858.CD005194.pub2
Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL (2006) Psychological and behavioral treatment of insomnia: update of the recent evidence (1998–2004). Sleep 29(11):1398–1414
Mendelson WB (1995) Long-term follow-up of chronic insomnia. Sleep 18(8):698–701
Bain KT (2006) Management of chronic insomnia in elderly persons. Am J Geriatr Pharmacother 4(2):168–192. doi:10.1016/j.amjopharm.2006.06.006
Alessi CA, Schnelle JF (2000) Approach to sleep disorders in the nursing home setting. Review article. Sleep Med Rev 4(1):45–56. doi:10.1053/smrv.1999.0066
Lyne J, Quinlivan L, Byrne CA, Malone K, Walsh C (2011) Sleep hygiene use in a psychiatry outpatient setting. Ir Med J 104(2):49–50
Charlson F, Degenhardt L, McLaren J, Hall W, Lynskey M (2009) A systematic review of research examining benzodiazepine-related mortality. Pharmacoepidemiol Drug Saf 18(2):93–103. doi:10.1002/pds.1694
Anthierens S, Grypdonck M, De Pauw L, Christiaens T (2009) Perceptions of nurses in nursing homes on the usage of benzodiazepines. J Clin Nurs 18(22):3098–3106. doi:10.1111/j.1365-2702.2008.02758.x
Verrue CL, Petrovic M, Mehuys E, Remon JP, Vander Stichele R (2009) Pharmacists' interventions for optimization of medication use in nursing homes: a systematic review. Drugs Aging 26(1):37–49. doi:10.2165/0002512-200926010-000032613
Acknowledgements
We thank Prof. Dr. Thierry Christiaens from the Department of Family Medicine and Primary Care and Dr. Hans Debruyne, psychiatrist at the Dr. Guislain Centre for Psychiatry, for their contribution.
Competing interest
There are no competing interests to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bourgeois, J., Elseviers, M.M., Azermai, M. et al. Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages. Eur J Clin Pharmacol 68, 833–844 (2012). https://doi.org/10.1007/s00228-011-1188-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-011-1188-z